Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Cencora
COR Rank #170 Health Care
$369.06 -0.83%

Key Statistics

Market Cap
$71.79B
Volume (24h)
$478.7M
P/E Ratio
44.3
EPS
$8.33
1 Day
-0.83%
7 Day
+2.21%
YTD
+4.42%
Sector
Health Care
S&P 500 Rank
#170
52W Low: $323.22 52W High: $429.66

About Cencora

Cencora is a pharmaceutical company that develops, manufactures, and commercializes a portfolio of generic and specialty pharmaceutical products, including respiratory and dermatology treatments. The company's product offerings include a range of generic and branded medications, as well as a pipeline of in-development products. As a leading player in the pharmaceutical industry, Cencora plays a critical role in providing affordable and accessible healthcare solutions to patients worldwide.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,027.59 -2.32% JNJ — Johnson & Johnson $247.67 -0.31% ABBV — AbbVie $233.22 +0.49% MRK — Merck & Co. $121.20 -2.11% UNH — UnitedHealth Group $290.56 -0.92% AMGN — Amgen $384.71 -0.89% ABT — Abbott Laboratories $114.46 -1.62% TMO — Thermo Fisher Scientific $506.43 -2.82% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.